Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-benzyl-8-methyl-1,4,8-triazaspiro(4.5)decan-3-one
2. Pti-125
1. Simufilam [usan]
2. Pti-125
3. Pti-910
4. C0105
5. 6nv440yio0
6. C0105m
7. C-0105
8. 1224591-33-6
9. 1-benzyl-8-methyl-1,4,8-triazaspiro(4.5)decan-2-one
10. 1,4,8-triazaspiro(4.5)decan-2-one, 8-methyl-1-(phenylmethyl)-
11. 1-benzyl-8-methyl-1,4,8-triazaspiro[4.5]decan-2-one
12. Simufilam [inn]
13. Unii-6nv440yio0
14. Chembl4650230
15. Schembl12627054
16. Ex-a5320
17. Who 11778
18. Hy-139142
19. Cs-0179880
| Molecular Weight | 259.35 g/mol |
|---|---|
| Molecular Formula | C15H21N3O |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 259.168462302 g/mol |
| Monoisotopic Mass | 259.168462302 g/mol |
| Topological Polar Surface Area | 35.6 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 330 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Simufilam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Simufilam, including repackagers and relabelers. The FDA regulates Simufilam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Simufilam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Simufilam supplier is an individual or a company that provides Simufilam active pharmaceutical ingredient (API) or Simufilam finished formulations upon request. The Simufilam suppliers may include Simufilam API manufacturers, exporters, distributors and traders.
Simufilam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Simufilam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Simufilam GMP manufacturer or Simufilam GMP API supplier for your needs.
A Simufilam CoA (Certificate of Analysis) is a formal document that attests to Simufilam's compliance with Simufilam specifications and serves as a tool for batch-level quality control.
Simufilam CoA mostly includes findings from lab analyses of a specific batch. For each Simufilam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Simufilam may be tested according to a variety of international standards, such as European Pharmacopoeia (Simufilam EP), Simufilam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Simufilam USP).
LOOKING FOR A SUPPLIER?
